Nuvectis Pharma
NVCT
NVCT
62 hedge funds and large institutions have $34.9M invested in Nuvectis Pharma in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $32M → $34.9M (+$2.91M)
0.42% more ownership
Funds ownership: 16.55% → 16.97% (+0.42%)
Holders
62
Holding in Top 10
–
Calls
$158K
Puts
$1K
Top Buyers
| 1 | +$672K | |
| 2 | +$561K | |
| 3 | +$259K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$250K |
| 5 |
OCM
Occam Crest Management
Darien,
Connecticut
|
+$233K |
Top Sellers
| 1 | -$247K | |
| 2 | -$180K | |
| 3 | -$157K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$96.9K |
| 5 |
BWP
Baldwin Wealth Partners
Marion,
Massachusetts
|
-$94.2K |
